NEW YORK (GenomeWeb News) — Third Wave Technologies today said fourth-quarter revenues increased 17 percent as R&D spending nearly doubled and net loss narrowed 8 percent.  
 
Total receipts for the three months ended Dec. 31, 2006, increased to $6.8 million from $5.8 million year over year.
 
Revenue from molecular diagnostics rose to $5.8 million from $4.3 million, but receipts from research products declined to $954,000 from $2.4 million.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.